Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202181531> ?p ?o ?g. }
- W3202181531 abstract "Depression is a common mental illness leading to upset or anxiety, with a high incidence rate in the world. Depression can lead to suicidal thoughts and behavior. The present study aimed to evaluate the effect of the direct oral anticoagulant rivaroxaban (RVX), in the model of depression induced by chronic unpredicted mild stress (CUMS) in rats. Fifty-six male Wister rats were randomly divided into seven experimental groups (8 rats/group); Group 1: Control group given vehicle per oral (p.o.), Group 2: RVXL-control group (received rivaroxaban 20 mg/kg/day, p.o..), Group 3: RVXH-control group (received rivaroxaban 30 mg/kg/day, p.o.), Group 4: chronic unpredictable mild stress (CUMS) group, Group 5: FLX-treated CUMS group (received fluoxetine 10 mg/kg/day, p.o..), Group 6: RVXL-treated CUMS group (received rivaroxaban 20 mg/kg/day, p.o.), and Group 7: RVXH-treated CUMS group (received rivaroxaban 30 mg/kg/day, p.o.). The rats received the drugs from the first day of the experiment and continued till 4 weeks—the duration of the study. The following were measured: monoamine neurotransmitters, malondialdehyde (MDA), total nitrite/nitrate (NOx), reduced glutathione (GSH), superoxide dismutase (SOD), Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88), nuclear factor‐kappa B (NF‐κB), tumor necrosis factor-α (TNF-α), brain-derived neurotrophic factor (BDNF), and vascular endothelial growth factor-A (VEGF-A). A forced swimming test (FST) was done. Furthermore, histological changes and glial fibrillary acidic protein (GFAP) immunoexpression were evaluated. CUMS showed a significant decrease in hypothalamic neurotransmitters, hippocampal GSH, SOD, BNDF, and VEGF-A with a significant increase in hippocampal MDA, NOx, NF-kβ, Myd88, TLR4, TNF-α, and GFAP immunoexpression. RVX showed significant improvement in all parameters ( p - value < 0.0001). In conclusion, RVX in a dose-dependent manner possesses potent ameliorative effects against depression by reducing the oxidative stress and inflammatory process, through the regulation of the TLR4/Myd88/NF-kβ signaling pathway." @default.
- W3202181531 created "2021-10-11" @default.
- W3202181531 creator A5052044150 @default.
- W3202181531 creator A5054584719 @default.
- W3202181531 creator A5059303055 @default.
- W3202181531 creator A5064062758 @default.
- W3202181531 creator A5073536869 @default.
- W3202181531 creator A5084258374 @default.
- W3202181531 date "2021-09-24" @default.
- W3202181531 modified "2023-10-03" @default.
- W3202181531 title "Rivaroxaban Modulates TLR4/Myd88/NF-Kβ Signaling Pathway in a Dose-Dependent Manner With Suppression of Oxidative Stress and Inflammation in an Experimental Model of Depression" @default.
- W3202181531 cites W1516311606 @default.
- W3202181531 cites W1544106726 @default.
- W3202181531 cites W1561180876 @default.
- W3202181531 cites W1590457525 @default.
- W3202181531 cites W1732278986 @default.
- W3202181531 cites W1816743455 @default.
- W3202181531 cites W1949718528 @default.
- W3202181531 cites W1968335535 @default.
- W3202181531 cites W1968699748 @default.
- W3202181531 cites W1976475530 @default.
- W3202181531 cites W1976734955 @default.
- W3202181531 cites W1980555794 @default.
- W3202181531 cites W1981633985 @default.
- W3202181531 cites W1986211748 @default.
- W3202181531 cites W2001028008 @default.
- W3202181531 cites W2003674452 @default.
- W3202181531 cites W2019315395 @default.
- W3202181531 cites W2019678208 @default.
- W3202181531 cites W2020328216 @default.
- W3202181531 cites W2020867780 @default.
- W3202181531 cites W2041796079 @default.
- W3202181531 cites W2044219916 @default.
- W3202181531 cites W2046792512 @default.
- W3202181531 cites W2046846997 @default.
- W3202181531 cites W2050961629 @default.
- W3202181531 cites W2055123265 @default.
- W3202181531 cites W2058728593 @default.
- W3202181531 cites W2060415305 @default.
- W3202181531 cites W2068021881 @default.
- W3202181531 cites W2069132215 @default.
- W3202181531 cites W2070703400 @default.
- W3202181531 cites W2079306370 @default.
- W3202181531 cites W2081113298 @default.
- W3202181531 cites W2081356986 @default.
- W3202181531 cites W2087973865 @default.
- W3202181531 cites W2099540110 @default.
- W3202181531 cites W2126795224 @default.
- W3202181531 cites W2131016140 @default.
- W3202181531 cites W2140864155 @default.
- W3202181531 cites W2157530259 @default.
- W3202181531 cites W2160779535 @default.
- W3202181531 cites W2269289848 @default.
- W3202181531 cites W2321547540 @default.
- W3202181531 cites W2561406710 @default.
- W3202181531 cites W2583115659 @default.
- W3202181531 cites W2593976960 @default.
- W3202181531 cites W260353343 @default.
- W3202181531 cites W2752411745 @default.
- W3202181531 cites W2759556325 @default.
- W3202181531 cites W2765484555 @default.
- W3202181531 cites W2765999349 @default.
- W3202181531 cites W2790589817 @default.
- W3202181531 cites W2806272929 @default.
- W3202181531 cites W2808140956 @default.
- W3202181531 cites W2883958957 @default.
- W3202181531 cites W2888000601 @default.
- W3202181531 cites W2952541102 @default.
- W3202181531 cites W2954678794 @default.
- W3202181531 cites W2955078696 @default.
- W3202181531 cites W2962528302 @default.
- W3202181531 cites W2964461736 @default.
- W3202181531 cites W2971983547 @default.
- W3202181531 cites W2998650899 @default.
- W3202181531 cites W2999621338 @default.
- W3202181531 cites W3021410291 @default.
- W3202181531 cites W3021794650 @default.
- W3202181531 cites W3043862457 @default.
- W3202181531 cites W4239346618 @default.
- W3202181531 doi "https://doi.org/10.3389/fphar.2021.715354" @default.
- W3202181531 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8497790" @default.
- W3202181531 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34630092" @default.
- W3202181531 hasPublicationYear "2021" @default.
- W3202181531 type Work @default.
- W3202181531 sameAs 3202181531 @default.
- W3202181531 citedByCount "11" @default.
- W3202181531 countsByYear W32021815312022 @default.
- W3202181531 countsByYear W32021815312023 @default.
- W3202181531 crossrefType "journal-article" @default.
- W3202181531 hasAuthorship W3202181531A5052044150 @default.
- W3202181531 hasAuthorship W3202181531A5054584719 @default.
- W3202181531 hasAuthorship W3202181531A5059303055 @default.
- W3202181531 hasAuthorship W3202181531A5064062758 @default.
- W3202181531 hasAuthorship W3202181531A5073536869 @default.
- W3202181531 hasAuthorship W3202181531A5084258374 @default.
- W3202181531 hasBestOaLocation W32021815311 @default.
- W3202181531 hasConcept C126322002 @default.
- W3202181531 hasConcept C134018914 @default.
- W3202181531 hasConcept C136569192 @default.
- W3202181531 hasConcept C160539049 @default.